Intravenous Immune Globulin in the Therapy of Myocarditis and Acute Cardiomyopathy

Abstract

In this series of patients with new-onset dilated cardiomyopathy treated with high-dose immune globulin, LVEF improved 17 EF units. The effectiveness of intravenous immune globulin therapy in this disorder should be evaluated in a randomized, multicenter trial.